Keep sensitive categories inside qualified B2B discussions.
Qualified B2B enquiries only
Compliance-led access for regulated healthcare supply.
Aura Med supports qualified teams working with medical cannabis-related supply, pharmacy-channel products and specialty health categories where lawful routes need careful review.
- Licensed B2B conversations
- Document-ready review
- European route support
- No consumer retail enquiries
Start with files, role, country and intended professional use.
Medical cannabis and adjacent health supply categories need context.
Visible working context
Show the category without over-explaining it.
The site should feel like a real supply-chain partner, not a public catalogue. Images can carry trust faster than long copy.
- Representative imagery without ownership overclaims.
- Route and document context before price discussion.
- Suitable for licensed buyers, distributors and producers.
Start with the least risky next step
Start broad. Narrow only when the case is qualified.
For regulated categories, the first job is not selling more. It is understanding whether the route is worth opening.
We know the country and channel.
Use the full intake when your team can describe the category, destination and professional use case.
Open full intakeWe need a quick fit check.
Send the basics first. Aura Med returns whether the request is workable, blocked or document-dependent.
Use short templateWe need internal alignment.
Use a short summary before supplier details, pricing or route assumptions expand.
Prepare handoffBuilt from European market patterns
What serious operators make visible early.
Keep public content simple: quality awareness, route discipline and a professional contact path.
Market access framing
Route before transaction
Sensitive supply is not simple trading. Route, qualification and files come before commercial escalation.
GMP / GDP awareness
Quality language buyers recognise
Quality, release, storage and distribution signals should appear as review checkpoints, not unsupported claims.
White-label path
Channel route needs more than product interest
Distributor and pharmacy-channel routes need packaging, storage, release and country feasibility to be checked early.